MedTrace Logo

Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs

NCT03602703 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2020-04-09

No results posted yet for this study

Summary

Case control Study to assess the difference of immune cell responses between patients with chronic HCV- related liver cirrhosis who develop HCC after treatment with DAAs and those who do not develop HCC

Conditions

  • Drug-Induced Liver Injury

Interventions

DIAGNOSTIC_TEST

Flow cytometry and Western Blot analysis

Diagnostic tests

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Haidi Ramadan, Lecturer · Lecturer

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2019-09-01
Completion
2019-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03602703 on ClinicalTrials.gov